447 related articles for article (PubMed ID: 31473142)
1. Pluripotent Stem Cell-Based Therapeutics for Muscular Dystrophies.
Selvaraj S; Kyba M; Perlingeiro RCR
Trends Mol Med; 2019 Sep; 25(9):803-816. PubMed ID: 31473142
[TBL] [Abstract][Full Text] [Related]
2. Generation of human myogenic progenitors from pluripotent stem cells for in vivo regeneration.
Kim H; Perlingeiro RCR
Cell Mol Life Sci; 2022 Jul; 79(8):406. PubMed ID: 35802202
[TBL] [Abstract][Full Text] [Related]
3. Myogenic Progenitors from Mouse Pluripotent Stem Cells for Muscle Regeneration.
Magli A; Incitti T; Perlingeiro RC
Methods Mol Biol; 2016; 1460():191-208. PubMed ID: 27492174
[TBL] [Abstract][Full Text] [Related]
4. Stem cell therapies to treat muscular dystrophy: progress to date.
Meregalli M; Farini A; Parolini D; Maciotta S; Torrente Y
BioDrugs; 2010 Aug; 24(4):237-47. PubMed ID: 20623990
[TBL] [Abstract][Full Text] [Related]
5. Genomic Safe Harbor Expression of PAX7 for the Generation of Engraftable Myogenic Progenitors.
Kim H; Selvaraj S; Kiley J; Azzag K; Garay BI; Perlingeiro RCR
Stem Cell Reports; 2021 Jan; 16(1):10-19. PubMed ID: 33275879
[TBL] [Abstract][Full Text] [Related]
6. iMyoblasts for ex vivo and in vivo investigations of human myogenesis and disease modeling.
Guo D; Daman K; Chen JJ; Shi MJ; Yan J; Matijasevic Z; Rickard AM; Bennett MH; Kiselyov A; Zhou H; Bang AG; Wagner KR; Maehr R; King OD; Hayward LJ; Emerson CP
Elife; 2022 Jan; 11():. PubMed ID: 35076017
[TBL] [Abstract][Full Text] [Related]
7. Generation of skeletal muscle cells from embryonic and induced pluripotent stem cells as an in vitro model and for therapy of muscular dystrophies.
Salani S; Donadoni C; Rizzo F; Bresolin N; Comi GP; Corti S
J Cell Mol Med; 2012 Jul; 16(7):1353-64. PubMed ID: 22129481
[TBL] [Abstract][Full Text] [Related]
8. Premyogenic progenitors derived from human pluripotent stem cells expand in floating culture and differentiate into transplantable myogenic progenitors.
Sakai-Takemura F; Narita A; Masuda S; Wakamatsu T; Watanabe N; Nishiyama T; Nogami K; Blanc M; Takeda S; Miyagoe-Suzuki Y
Sci Rep; 2018 Apr; 8(1):6555. PubMed ID: 29700358
[TBL] [Abstract][Full Text] [Related]
9. Gene Editing in Human Pluripotent Stem Cells: Recent Advances for Clinical Therapies.
Şişli HB; Hayal TB; Seçkin S; Şenkal S; Kıratlı B; Şahin F; Doğan A
Adv Exp Med Biol; 2020; 1237():17-28. PubMed ID: 31728915
[TBL] [Abstract][Full Text] [Related]
10. Pluripotent Stem Cells for Gene Therapy of Degenerative Muscle Diseases.
Loperfido M; Steele-Stallard HB; Tedesco FS; VandenDriessche T
Curr Gene Ther; 2015; 15(4):364-80. PubMed ID: 26122099
[TBL] [Abstract][Full Text] [Related]
11. Stem cell therapy for muscular dystrophies.
Biressi S; Filareto A; Rando TA
J Clin Invest; 2020 Nov; 130(11):5652-5664. PubMed ID: 32946430
[TBL] [Abstract][Full Text] [Related]
12. Gene-editing, immunological and iPSCs based therapeutics for muscular dystrophy.
Singh S; Singh T; Kunja C; Dhoat NS; Dhania NK
Eur J Pharmacol; 2021 Dec; 912():174568. PubMed ID: 34656607
[TBL] [Abstract][Full Text] [Related]
13. Stem cell-based therapies for Duchenne muscular dystrophy.
Sun C; Serra C; Lee G; Wagner KR
Exp Neurol; 2020 Jan; 323():113086. PubMed ID: 31639376
[TBL] [Abstract][Full Text] [Related]
14. Functional myogenic engraftment from mouse iPS cells.
Darabi R; Pan W; Bosnakovski D; Baik J; Kyba M; Perlingeiro RC
Stem Cell Rev Rep; 2011 Nov; 7(4):948-57. PubMed ID: 21461712
[TBL] [Abstract][Full Text] [Related]
15. Cellular Therapies for Muscular Dystrophies: Frustrations and Clinical Successes.
Negroni E; Bigot A; Butler-Browne GS; Trollet C; Mouly V
Hum Gene Ther; 2016 Feb; 27(2):117-26. PubMed ID: 26652770
[TBL] [Abstract][Full Text] [Related]
16. Engraftment of human induced pluripotent stem cell-derived myogenic progenitors restores dystrophin in mice with duchenne muscular dystrophy.
He R; Li H; Wang L; Li Y; Zhang Y; Chen M; Zhu Y; Zhang C
Biol Res; 2020 May; 53(1):22. PubMed ID: 32430065
[TBL] [Abstract][Full Text] [Related]
17. Stem Cells: The Game Changers of Human Cardiac Disease Modelling and Regenerative Medicine.
Parrotta EI; Scalise S; Scaramuzzino L; Cuda G
Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31744081
[TBL] [Abstract][Full Text] [Related]
18. Can Human Pluripotent Stem Cell-Derived Cardiomyocytes Advance Understanding of Muscular Dystrophies?
Kalra S; Montanaro F; Denning C
J Neuromuscul Dis; 2016 Aug; 3(3):309-332. PubMed ID: 27854224
[TBL] [Abstract][Full Text] [Related]
19. Perspectives on hiPSC-Derived Muscle Cells as Drug Discovery Models for Muscular Dystrophies.
Abati E; Sclarandi E; Comi GP; Parente V; Corti S
Int J Mol Sci; 2021 Sep; 22(17):. PubMed ID: 34502539
[TBL] [Abstract][Full Text] [Related]
20. Potential Therapies Using Myogenic Stem Cells Combined with Bio-Engineering Approaches for Treatment of Muscular Dystrophies.
Motohashi N; Shimizu-Motohashi Y; Roberts TC; Aoki Y
Cells; 2019 Sep; 8(9):. PubMed ID: 31514443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
